44 related articles for article (PubMed ID: 23136768)
1. [Suppression of vascular endothelium hyperpermeability by cell-permeating peptide inhibitors of myosin light chain kinase].
Khapchaev AIu; Samsonov MV; Kazakova OA; Vilitkevich EL; Sidorova MV; Az'muko AA; Molokoedov AS; Bespalova ZhD; Shirinskiĭ VP
Biofizika; 2012; 57(5):764-70. PubMed ID: 23136768
[TBL] [Abstract][Full Text] [Related]
2. [Novel peptide inhibitors of the myosin light chain kinase suppress hyperpermeability of vascular endothelium].
Marchenko AV; Stepanova EO; Sekridova AV; Sidorova MV; Bushuev VN; Bespalova ZhD; Shirinskiĭ VP
Biofizika; 2010; 55(6):1008-13. PubMed ID: 21268344
[TBL] [Abstract][Full Text] [Related]
3. Design of peptidase-resistant peptide inhibitors of myosin light chain kinase.
Khapchaev AY; Kazakova OA; Samsonov MV; Sidorova MV; Bushuev VN; Vilitkevich EL; Az'muko AA; Molokoedov AS; Bespalova ZD; Shirinsky VP
J Pept Sci; 2016 Nov; 22(11-12):673-681. PubMed ID: 27699916
[TBL] [Abstract][Full Text] [Related]
4. [Penetrating peptide inhibitor of the myosin light chain kinase suppresses hyperpermeability of vascular endothelium].
Marchenko AV; Sidorova MV; Sekridova AV; Bushuev VN; Lakomkin VL; Orlova TsR; Stepanova OV; Kapel'ko VI; Watterson DM; Van Eldik LJ; Bespalova ZhD; Shirinskiĭ VP
Ross Fiziol Zh Im I M Sechenova; 2009 May; 95(5):507-15. PubMed ID: 19569527
[TBL] [Abstract][Full Text] [Related]
5. Minimum requirements for inhibition of smooth-muscle myosin light-chain kinase by synthetic peptides.
Hunt JT; Floyd DM; Lee VG; Little DK; Moreland S
Biochem J; 1989 Jan; 257(1):73-8. PubMed ID: 2920029
[TBL] [Abstract][Full Text] [Related]
6. A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns.
Reynoso R; Perrin RM; Breslin JW; Daines DA; Watson KD; Watterson DM; Wu MH; Yuan S
Shock; 2007 Nov; 28(5):589-95. PubMed ID: 17577141
[TBL] [Abstract][Full Text] [Related]
7. Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells.
Schini VB; Katusic ZS; Vanhoutte PM
J Pharmacol Exp Ther; 1990 Dec; 255(3):994-1000. PubMed ID: 2175809
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel classes of protein kinase inhibitors using combinatorial peptide chemistry based on functional genomics knowledge.
Lukas TJ; Mirzoeva S; Slomczynska U; Watterson DM
J Med Chem; 1999 Mar; 42(5):910-9. PubMed ID: 10072688
[TBL] [Abstract][Full Text] [Related]
10. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation.
Zeng L; Xu H; Chew TL; Eng E; Sadeghi MM; Adler S; Kanwar YS; Danesh FR
FASEB J; 2005 Nov; 19(13):1845-7. PubMed ID: 16160062
[TBL] [Abstract][Full Text] [Related]
11. Role of the actin cytoskeleton in regulating endothelial permeability in venules.
Valeski JE; Baldwin AL
Microcirculation; 2003 Oct; 10(5):411-20. PubMed ID: 14557824
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo.
Fürst R; Bubik MF; Bihari P; Mayer BA; Khandoga AG; Hoffmann F; Rehberg M; Krombach F; Zahler S; Vollmar AM
Mol Pharmacol; 2008 Jul; 74(1):1-8. PubMed ID: 18413663
[TBL] [Abstract][Full Text] [Related]
13. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
14. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways.
Lal BK; Varma S; Pappas PJ; Hobson RW; Durán WN
Microvasc Res; 2001 Nov; 62(3):252-62. PubMed ID: 11678628
[TBL] [Abstract][Full Text] [Related]
15. The role of the cytoskeleton in cellular adhesion molecule expression in tumor necrosis factor-stimulated endothelial cells.
VandenBerg E; Reid MD; Edwards JD; Davis HW
J Cell Biochem; 2004 Apr; 91(5):926-37. PubMed ID: 15034928
[TBL] [Abstract][Full Text] [Related]
16. Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.
Presta M; Rusnati M; Urbinati C; Sommer A; Ragnotti G
J Cell Physiol; 1991 Dec; 149(3):512-24. PubMed ID: 1660485
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen peroxide-induced cytoskeletal rearrangement in cultured pulmonary endothelial cells.
Zhao Y; Davis HW
J Cell Physiol; 1998 Mar; 174(3):370-9. PubMed ID: 9462699
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits reactive oxygen species formation and vascular hyperpermeability following haemorrhagic shock.
Tharakan B; Hunter FA; Smythe WR; Childs EW
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):939-44. PubMed ID: 20528978
[TBL] [Abstract][Full Text] [Related]
19. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
Chang YS; Munn LL; Hillsley MV; Dull RO; Yuan J; Lakshminarayanan S; Gardner TW; Jain RK; Tarbell JM
Microvasc Res; 2000 Mar; 59(2):265-77. PubMed ID: 10684732
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
